EOFlow Overview
- Year Founded
-
2011
- Status
-
Public
- Employees
-
63
- Stock Symbol
-
294090
- Investments
-
4
- Share Price
-
$1.01
- (As of Friday Closing)
EOFlow General Information
Description
EOFlow Co Ltd is an operator of a wearable disposable drug delivery platform that manufactures wearable insulin pumps and other related products in South Korea.
Contact Information
Website
www.eoflow.comCorporate Office
- 25, Gyeongchung-daero 295beon-gil, Gonjiam-eup
- Gonjiam-eup
- Gwangju, Gyeonggi 12813
- South Korea
Corporate Office
- 25, Gyeongchung-daero 295beon-gil, Gonjiam-eup
- Gonjiam-eup
- Gwangju, Gyeonggi 12813
- South Korea
EOFlow Stock Performance
As of 21-Mar-2025, EOFlow’s stock price is $1.01. Its current market cap is $30.9M with 30.4M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.01 | $1.07 | $0.99 - $13.55 | $30.9M | 30.4M | 1.19M | -$1.55 |
EOFlow Financials Summary
As of 30-Jun-2026, EOFlow has a trailing 12-month revenue of $1.37M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 82,423 | 89,936 | ||
| Revenue | 1,375 | 2,579 | 3,841 | 5,040 |
| EBITDA | 56,515 | (16,207) | (136,071) | (39,330) |
| Net Income | 42,591 | (29,726) | (139,217) | (47,371) |
| Total Assets | 20,098 | 25,261 | 33,284 | 62,613 |
| Total Debt | 14,437 | 13,665 | 22,590 | 11,417 |
EOFlow Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
EOFlow Comparisons
Industry
Financing
Details
EOFlow Competitors (2)
One of EOFlow’s 2 competitors is Tandem Diabetes Care, a Formerly VC-backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Tandem Diabetes Care | Formerly VC-backed | San Diego, CA | ||||
| Insulet | Formerly VC-backed | Acton, MA |
EOFlow Patents
EOFlow Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026059033-A1 | Method, device, and program for adjusting insulin injection amount based on predicted blood glucose | Pending | 12-Sep-2024 | ||
| WO-2025264049-A1 | Liquid medicine injection device | Pending | 21-Jun-2024 | ||
| WO-2025014075-A1 | System for injecting multiple medical liquids | Inactive | 10-Jul-2023 | ||
| WO-2024232690-A1 | Liquid medicine injection device | Inactive | 09-May-2023 | ||
| WO-2024225542-A1 | Liquid medicine injection device | Inactive | 24-Apr-2023 | A61M5/14248 |
EOFlow Signals
EOFlow Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
EOFlow Investments (4)
EOFlow’s most recent deal was a Later Stage VC with Biolinq for . The deal was made on 17-Oct-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Biolinq | 17-Oct-2022 | Later Stage VC | Monitoring Equipment | ||
| SINOFLOW Company | 26-Jan-2022 | Joint Venture | Therapeutic Devices | ||
| DS Techno (4,850 Square Meter Land and 1,523.28 Square Meter Building in Gwangju, South Korea) | 30-Jun-2021 | Corporate Asset Purchase | Buildings and Property | ||
| SanPlena | 01-Jan-2021 | Joint Venture | Drug Discovery |
EOFlow ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
32.54 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,593
Rank
Percentile
Technology Hardware
Industry
of 556
Rank
Percentile
Electronics Equipment
Subindustry
of 106
Rank
Percentile
EOFlow Exits (1)
EOFlow’s most recent exit was on 01-Jan-2021 from SanPlena. The exit was categorized as with 2 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| SanPlena | 01-Jan-2021 | Completed |
|
EOFlow FAQs
-
When was EOFlow founded?
EOFlow was founded in 2011.
-
Where is EOFlow headquartered?
EOFlow is headquartered in Gwangju, South Korea.
-
What is the size of EOFlow?
EOFlow has 63 total employees.
-
What industry is EOFlow in?
EOFlow’s primary industry is Drug Delivery.
-
Is EOFlow a private or public company?
EOFlow is a Public company.
-
What is EOFlow’s stock symbol?
The ticker symbol for EOFlow is 294090.
-
What is the current stock price of EOFlow?
As of 21-Mar-2025 the stock price of EOFlow is $1.01.
-
What is the current market cap of EOFlow?
The current market capitalization of EOFlow is $30.9M.
-
What is EOFlow’s current revenue?
The trailing twelve month revenue for EOFlow is $1.37M.
-
Who are EOFlow’s competitors?
Tandem Diabetes Care and Insulet are competitors of EOFlow.
-
What is EOFlow’s annual earnings per share (EPS)?
EOFlow’s EPS for 12 months was -$1.55.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process